Gerrit Dispersyn
2017
In 2017, Gerrit Dispersyn earned a total compensation of $231.2K as Chief Development Officer at RXi Pharmaceuticals.
Compensation breakdown
| Option Awards | $44,555 |
|---|---|
| Salary | $186,346 |
| Other | $275 |
| Total | $231,176 |
Dispersyn received $186.3K in salary, accounting for 81% of the total pay in 2017.
Dispersyn also received $44.6K in option awards and $275 in other compensation.
Rankings
In 2017, Gerrit Dispersyn's compensation ranked 13,837th out of 14,666 executives tracked by ExecPay. In other words, Dispersyn earned more than 5.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 13,837 out of 14,666 | 6th |
Division Manufacturing | 5,430 out of 5,772 | 6th |
Major group Chemicals And Allied Products | 1,951 out of 2,075 | 6th |
Industry group Drugs | 1,626 out of 1,731 | 6th |
Industry Pharmaceutical Preparations | 1,246 out of 1,333 | 7th |
Source: SEC filing on April 26, 2018.
Dispersyn's colleagues
We found three more compensation records of executives who worked with Gerrit Dispersyn at RXi Pharmaceuticals in 2017.